UCB

Allée de la Recherche
60
1070 BRUXELLES
Belgium

[email protected] +32 473 95 52 98 www.ucb.com

Follow them

Type
- Company
Core business
- Production
- R&D
Technology
- Cell therapy
- Gene therapy
Therapeutic area

UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, focusing on innovative treatments for severe diseases in immunology and neurology.

Related projects

Projects

NEMO

GTRP-DIAT

Targetum

All member's projects

Related news

News

UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences

UCB2

RYSTIGGO® (rozanolixizumab) receives approval in Japan for two new administration methods as UCB begins ONWARD program for patient support

All member's news